116
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Study of the acute and repeated dose 28-day oral toxicity in mice treated with PT-31, a molecule with a potential antipsychotic profile

, , , , , , , , , , , & ORCID Icon show all
Pages 705-715 | Received 21 Jan 2022, Accepted 07 Apr 2022, Published online: 21 Apr 2022

References

  • Agostinho FR, Scaini G, Ferreira GK, Jeremias IC, Réus GZ, Rezin GT, Castro AA, Zugno AI, Quevedo J, Streck EL. 2009. Effects of olanzapine, fluoxetine and olanzapine/fluoxetine on creatine kinase activity in rat brain. Brain Res Bull. 80(6):337–340.
  • Aktas M, Lefebvre HP, Toutain PL, Braun JP. 1995. Disposition of creatine kinase activity in dog plasma following intravenous and intramuscular injection of skeletal muscle homogenates. J Vet Pharmacol Ther. 18(1):1–6.
  • Alexander J, Tibrewal P. 2010. Quetiapine-induced leucopenia. Aust N Z J Psychiatry. 44(8):767–768.
  • Atmaca, M, Kilic, F, Temizkan, A, Ustundag, B. 2013. What about platelet counts in clozapine users? Rev Recent Clin Trials. 8(2):74–77.
  • Andrade RF. 2015. Antipsicóticos de segunda geração no tratamento da esquizofrenia. Rev Acad Oswaldo Cruz. 7:1–14.
  • Antonelli-Ushirobira TM, Kaneshima EN, Gabriel M, Audi EA, Marques LC, Mello JCP. 2010. Acute and subchronic toxicological evaluation of the semipurified extract of seeds of guaraná (Paullinia cupana) in rodents. Food Chem Toxicol. 48(7):1817–1820.
  • Arivazhahan A, Bairy LK, Nayak V, Kunder SK. 2017. A study to assess the therapeutic effect of enalapril on olanzapine induced metabolic syndrome in Wistar Rats. J Clin Diagn Res. 11(2):FF01–FF06.
  • Aronson JK. 2009. Medication errors: definitions and classification. Br J Clin Pharmacol. 67(6):599–604.
  • Bessman SP, Carpenter CL. 1985. The creatine-creatine phosphate energy shuttle. Annu Rev Biochem. 54:831–862.
  • Betti AH, Antonio CB, Herzfeldt V, Pitta MGR, Pitta IR, Rego J-L, Rego J-C, Vaudry D, Rates SMK. 2019. PT-31, a putative α2-adrenoceptor agonist, is effective in schizophrenia cognitive symptoms in mice. Behav Pharmacol. 30(7):574–587.
  • Bigolin C, Oliveira TSS, Silva LC, Ayres T, Menezes JM, Pitta IR, Charão MF, Betti AH. 2020. Evaluation of the potential toxicity of haloperidol, clozapine and a new putative antipsychotic molecule, PT-31, in an alternative toxicity model, C. elegans. IJIER. 8(6):502–512.
  • BRASIL 2008. Lei n° 11.794, de 8 de outubro de 2008: Regulamenta o inciso VII do § 1o do art. 225 da Constituição Federal, estabelecendo procedimentos para o uso científico de animais; revoga a Lei no 6.638, de 8 de maio de 1979; e dá outras providências. Brasília (BR): Presidência da República; [accessed 2021 Apr 30]. http://www.planalto.gov.br/ccivil_03/_ato2007-2010/2008/lei/l11794.htm.
  • Brunton LL, Chabner BA, Knollmann BC. 2012. Goodman and Gilman’s the pharmacological basis of therapeutics. New York (NY): McGraw-Hill.
  • Cahn W, Pol HEH, Lems EBTE, van Haren NEM, Schnack HG, van der Linden JA, Schothorst PF, van Engeland H, Kahn RS. 2002. Brain volume changes in first-episode schizophrenia: a 1-year follow-up study. Arch Gen Psychiatry. 59(11):1002–1010.
  • Chou AIW, Lu M-L, Shen WW. 2014. Hepatotoxicity induced by clozapine: a case report and review of literature. Neuropsychiatr Dis Treat. 10:1585–1587.
  • CONCEA. 2018. Resolução Normativa n° 37: Diretriz da Prática de Eutanásia do CONCEA. Brasília (BR): Conselho Nacional de Controle de Experimentação Animal; [accessed 2020 May 7] https://www.ceua.ufv.br/wp-content/uploads/2018/03/DIRETRIZ-DA-PRATICA-DE-EUTANASIA-DO-CONCEA-ATUALIZADA1.pdf.
  • Cordioli AV, Gallois CB, Isolan L. 2011. Psicofármacos: Consulta Rápida, Porto Alegre (BR): Artmed.
  • Correll CU, Manu P, Olshanskiy V, Napolitano B, Kane JM, Malhotra AK. 2009. Cardiometabolic Risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA. 302(16):1765–1773.
  • David-Pereira A, Puga S, Gonçalves S, Amorim D, Silva C, Pertovaara A, Almeida A, Pinto-Ribeiro F. 2016. Metabotropic glutamate 5 receptor in the infralimbic cortex contributes to descending pain facilitation in healthy and arthritic animals. Neuroscience. 312:108–119.
  • De Meijer VE, Le HD, Meisel JA, Puder M. 2010. Repetitive orogastric gavage affects the phenotype of diet-induced obese mice. Physiol Behav. 100(4):387–393.
  • De With SAJ, Pulit SL, Staal WG, Kahn RS, Ophoff RA. 2017. More than 25 years of genetic studies of clozapine-induced agranulocytosis. Pharmacogenomics J. 17(4):304–311.
  • Del Campo A, Bustos C, Mascayano C, Acuña-Castillo C, Troncoso R, Rojo LE. 2018. Metabolic syndrome and antipsychotics: the role of mitochondrial fission/fusion imbalance. Front Endocrinol. 9:144.
  • Domecq JP, Prutsky G, Leppin A, Sonbol MB, Altayar O, Undavalli C, Wang Z, Elraiyah T, Brito JP, Mauck KF, et al. 2015. Clinical review: drugs commonly associated with weight change: a systematic review and meta-analysis. J Clin Endocrinol Metab. 100(2):363–370.
  • Doweiko JP, Nompleggi DJ. 1991. The role of albumin in human physiology and pathophysiology, Part III: albumin and disease States. J Parenter Enteral Nutr. 15(4):476–483.
  • Ebdrup BH, Skimminge A, Rasmussen H, Aggernaes B, Oranje B, Lublin H, Baaré W, Glenthøj B. 2011. Progressive striatal and hippocampal volume loss in initially antipsychotic-naive, first-episode schizophrenia patients treated with quetiapine: relationship to dose and symptoms. Int J Neuropsychopharmacol. 14(1):69–82.
  • Elkis H, Gama C, Suplicy H, Tambascia M, Bressan R, Lyra R, Cavalcante S, Minicucci W. 2008. [Brazilian Consensus on second-generation antipsychotics and metabolic disorders]. Braz J Psychiatry. 30(1):77–85.
  • EUR-LEX. 2010. Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes. European Union (EU): European Union Law; [accessed 2021 Feb 10]. http://data.europa.eu/eli/dir/2010/63/oj.
  • Flanagan RJ, Dunk L. 2008. Haematological toxicity of drugs used in psychiatry. Hum Psychopharmacol Clin Exp. 23:27–41.
  • Fleischhacker WW, Sanchez R, Perry PP, Jin N, Peters-Strickland T, Johnson BR, Baker RA, Eramo A, McQuade RD, Carson WH, et al. 2014. Aripiprazole once-monthly for treatment of schizophrenia: double-blind, randomised, non-inferiority study. Br J Psychiatry. 205(2):135–144.
  • Fraguas D, Merchán-Naranjo J, Laita P, Parellada M, Moreno D, Ruiz-Sancho A, Cifuentes A, Giráldez M, Arango C. 2008. Metabolic and hormonal side effects in children and adolescents treated with second-generation antipsychotics. J Clin Psychiatry. 69(7):1166–1175.
  • Galili-Mosberg R, Gil-Ad I, Weizmann A, Melamed E, Offen D. 2000. Haloperidol – induced neurotoxicity – possible implications for tardive dyskinesia. J Neural Transm. 107(4):479–490.
  • García-Cabezas MA, Barbas H, Zikopoulos B. 2018. Parallel development of chromatin patterns, neuron morphology, and connections: potential for disruption in autism. Front Neuroanat. 12:70.
  • García-Cabezas MA, John YJ, Barbas H, Zikopoulos B. 2016. Distinction of neurons, glia and endothelial cells in the cerebral cortex: an algorithm based on cytological features. Front Neuroanat. 10:107.
  • Gardner DM, Baldessarini RJ, Waraich P. 2005. Modern antipsychotic drugs: a critical overview. CMAJ. 172(13):1703–1711.
  • Gautam S, Meena PS. 2011. Drug-emergent metabolic syndrome in patients with schizophrenia receiving atypical (second-generation) antipsychotics. Indian J Psychiatry. 53(2):128–133.
  • Girault EM, Guigas B, Alkemade A, Foppen E, Ackermans MT, Fleur SE, Fliers E, Kalsbeek A. 2014. Chronic treatment with olanzapine increases adiposity by changing fuel substrate and causes desensitization of the acute metabolic side effects. Naunyn Schmiedebergs Arch Pharmacol. 387(2):185–195.
  • Gora RH, Kerketta P, Baxla SL, Toppo R, Prasad R, Patra PH, Roy BK. 2014. Ameliorative Effect of Tephrosia purpurea in Arsenic-induced Nephrotoxicity in Rats. Toxicol Int. 21(1):78–83.
  • Groover S, Hegde A, Agarwal M, Sachdeva MS. 2012. Olanzapine-associated leukopenia and thrombocytopenia managed with lithium in a patient who developed leukopenia with clozapine in the past: a case report. Int Clin Psychopharmacol 14(6):117–119.
  • Hsu C-W, Lee Y, Lee C-Y, Lin P-Y. 2016. Neurotoxicity and nephrotoxicity caused by combined use of lithium and risperidone: a case report and literature review. BMC Pharmacol Toxicol. 17(1):59.
  • Huang T-L, Lee C-T. 2007. Low serum albumin and high ferritin levels in chronic hemodialysis patients with major depression. Psychiatry Res. 152(2–3):277–280.
  • Hwang YJ, Dixon SN, Reiss JP, Wald R, Parikh CR, Gandhi S, Shariff SZ, Pannu N, Nash DM, Rehman F, et al. 2014. Atypical antipsychotic drugs and the risk for acute kidney injury and other adverse outcomes in older adults: a population-based cohort study. Ann Intern Med. 161(4):242–248.
  • Ignácio ZM, Réus GZ, Abelaira HM, Titus SE, Carlessi AS, Luz JR, Matias BI, Bruchchen L, Carvalho-Silva M, Gomes LM, et al. 2015. Acute and chronic treatments with quetiapine increase mitochondrial respiratory chain complex activity in the rat brain. Curr Neurovasc Res. 12(3):283–292.
  • Insel TR. 2010. Rethinking schizophrenia. Nature. 468(7321):187–193.
  • Ito HT, Zhang S-J, Witter MP, Moser EI, Moser M-B. 2015. A prefrontal-thalamo-hippocampal circuit for goal-directed spatial navigation. Nature. 522(7554):50–55.
  • Jacob R, Chowdhury AN. 2008. Metabolic comorbidity in schizophrenia. Indian J Med Sci. 62(1):23–31.
  • Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV. 2002. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry. 63(10):892–909.
  • Laurent V, Westbrook RF. 2009. Inactivation of the infralimbic but not the prelimbic cortex impairs consolidation and retrieval of fear extinction. Learn Mem. 16(9):520–529.
  • Lee, J, Takeuchi, H, Fervaha, G, Powell, V, Bhaloo, A, Bies, R, Remington, G. 2015. The effect of clozapine on hematological indices: A 1-year follow-up study. J Clin Psychopharmacol. 35(5):510–516.
  • Legge SE, Walters JT. 2019. Genetics of clozapine-associated neutropenia: recent advances, challenges and future perspective. Pharmacogenomics. 20(4):279–290.
  • Minami C, Shimizu T, Mitani A. 2017. Neural activity in the prelimbic and infralimbic cortices of freely moving rats during social interaction: effect of isolation rearing. PLoS One. 12(5):e0176740.
  • Minns AB, Clark RF. 2012. Toxicology and overdose of atypical antipsychotics. J Emerg Med. 43(5):906–913.
  • Neubauer S. 2007. The failing heart-an engine out of fuel. N Engl J Med. 356(11):1140–1151.
  • Noh JS, Kang HJ, Kim EY, Sohn S, Chung YK, Kim SU, Gwag BJ. 2000. Haloperidol-induced neuronal apoptosis: role of p38 and c-Jun-NH(2)-terminal protein kinase. J Neurochem. 75(6):2327–2334.
  • OECD. 2001. Test Guideline 423: Acute Oral Toxicity – Acute Toxic Class Method. Paris (FR): Organisation for Economic Co-operation and Development; [accessed 2020 Oct 20]. https://ntp.niehs.nih.gov/iccvam/suppdocs/feddocs/oecd/oecd_gl423.pdf.
  • OECD. 2008. Test Guideline 407: Repeated Dose 28-day Oral Toxicity Study in Rodents. Paris (FR): Organisation for Economic Co-operation and Development; [accessed 2020 Jun 8]. https://ntp.niehs.nih.gov/iccvam/suppdocs/feddocs/oecd/oecdtg407-2008.pdf.
  • Parsons B, Allison DB, Loebel A, Williams K, Giller E, Romano S, Siu C. 2009. Weight effects associated with antipsychotics: a comprehensive database analysis. Schizophr Res. 110(1–3):103–110.
  • Randeva HS, Bangar V, Sailesh S, Hillhouse EW. 2000. Fatal cholestatic jaundice associated with amitriptyline. Int J Clin Pract. 54(6):405–406.
  • Rothschild MA, Oratz M, Schreiber SS. 1972. Albumin synthesis. N Engl J Med. 286(14):748–757.
  • Satoh H, Delbridge LM, Blatter LA, Bers DM. 1996. Surface: volume relationship in cardiac myocytes studied with confocal microscopy and membrane capacitance measurements: species-dependence and developmental effects. Biophys J. 70(3):1494–1504.
  • Shankar BR. 2007. Quetiapine-induced leucopenia and thrombocytopenia. Psychosomatics. 48(6):530–531.
  • Sharma V, Pandey D. 2010. Protective Role of Tinospora cordifolia against Lead-induced hepatotoxicity. Toxicol Int. 17(1):12–17.
  • Silva JCG, Dallegrave E, Rodrigues GZP, Bigolin C, Neumann TMSO, Schuster AC, Kayser JM, Staudt LBM, Moraes MF, Farias DG. 2020. Repeated dose of meloxicam induces genotoxicity and histopathological changes in cardiac tissue of mice. Drug Chem Toxicol. 18:1–12.
  • Singh KP, Singh MK, Singh M. 2016. Effects of prenatal exposure to antipsychotic risperidone on developmental neurotoxicity, apoptotic neurodegeneration and neurobehavioral sequelae in rat offspring. Int J Dev Neurosci. 52:13–23.
  • Singh KP, Singh MK. 2017. In utero exposure to atypical antipsychotic drug, risperidone: effects on fetal neurotoxicity in hippocampal region and cognitive impairment in rat offspring. Prog Neuropsychopharmacol Biol Psychiatry. 75:35–44.
  • Slim M, Medina-Caliz I, Gonzalez-Jimenez A, Cabello MR, Mayoral-Cleries F, Lucena MI, Andrade RJ. 2016. Hepatic safety of atypical antipsychotics: current evidence and future directions. Drug Saf. 39(10):925–943.
  • Smith KS, Graybiel AM. 2013. A dual operator view of habitual behavior reflecting cortical and striatal dynamics. Neuron. 79(2):361–374.
  • Stenvinkel P, Heimbürger O, Paultre F, Diczfalusy U, Wang T, Berglund L, Jogestrand T. 1999. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 55(5):1899–1911.
  • Stępnicki P, Kondej M, Kaczor AA. 2018. Current concepts and treatments of schizophrenia. Molecules. 23(8):2087.
  • Sudo RT, Calasans-Maia JA, Galdino SL, Lima MCA, Zapata-Sudo G, Hernandes MZ, Pitta IR. 2010. Interaction of morphine with a new alpha2-adrenoceptor agonist in mice. J Pain. 11(1):71–78.
  • Sudo RT, do Amaral RV, Monteiro CEDS, Pitta IDR, Lima MDC, Montes GC, Ririe DG, Hayashida K, Zapata-Sudo G. 2017. Antinociception induced by a novel α2A adrenergic receptor agonist in rodents acute and chronic pain models. Eur J Pharmacol. 815:210–218.
  • Tejaswi C, Mohanan S, Murugaiyan R, Karthikeyan K. 2015. Double trouble: cyclosporine-induced thrombocytosis in a patient with methotrexate toxicity: are they related? J Pharmacol Pharmacother. 6(3):160–162.
  • Ukai W, Ozawa H, Tateno M, Hashimoto E, Saito T. 2004. Neurotoxic potential of haloperidol in comparison with risperidone: implication of Akt-mediated signal changes by haloperidol. J Neural Transm. 111(6):667–681.
  • Unal B, Özbek ME, Aydın MD, Aydın N, Bulucu Z, Vuraler Ö, Odaci E, Sahin B, Kaplan S. 2004. Effect of haloperidol on the numeric density of neurons and nuclear height in the rat hippocampus: a stereological and histopathological study. Neurosci Res Comm. 34(1):1–9.
  • Van De Werd HJJM, Uylings HBM. 2014. Comparison of (stereotactic) parcellations in mouse prefrontal cortex. Brain Struct Funct. 219(2):433–459.
  • Varghese D, Kirkwood CK, Carroll NV. 2016. Prevalence of antidiabetic and antilipidemic medications in children and adolescents treated with atypical antipsychotics in a Virginia Medicaid Population. Ann Pharmacother. 50(6):463–470.
  • Verrico MM, Nace DA, Towers AL. 2000. Fulminant chemical hepatitis possibly associated with donepezil and sertraline therapy. J Am Geriatr Soc. 48(12):1659–1663.
  • Vo, QT, Thompson, DF. 2019. A review and assessment of drug-induced thrombocytosis. Ann Pharmacother. 53(5):523–536.
  • Wasti A, Ghani R, Manji MA, Ahmed N. 2017. Clozapine induced neutrophil cytotoxicity in rats. J Pak Med Assoc. 56(2):62–65.
  • WHO. 2019. Schizophrenia. Geneva (CH): World Health Organization; [accessed 2020 Mar 26]. http://www.who.int/mediacentre/factsheets/fs397/en/.
  • Zugno AI, Barcelos M, Oliveira L d, Canever L, Luca RDd, Fraga DB, Matos MP, Rezin GT, Scaini G, Búrigo M, et al. 2012. Energy metabolism, leptin, and biochemical parameters are altered in rats subjected to the chronic administration of olanzapine. Braz J Psychiatry. 34(2):168–175.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.